Research on AXL signaling in cancer is yielding molecular insights that may lead to targeted therapies. Studies are exploring the role of AXL in various types of cancer, including pancreatic ductal adenocarcinoma, lung cancer, and gastric cancer, and its potential impact on treatment resistance. The relationship between AXL signaling and other factors, such as immune checkpoint inhibition and the tumor microenvironment, is also being investigated.